Exclusive

Publication

Byline

Location

US Patent Issued on April 21 for "Method for the production of a product used for immune modulation and regeneration purposes in alopecia areata, androgenetic alopecia, scar, neurodegenerative inflammatory diseases" (Turkish Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,408, issued on April 21. "Method for the production of a product used for immune modulation and regeneration purposes in alopecia areata, ... Read More


US Patent Issued to University of South Florida on April 21 for "Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders" (Florida Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,409, issued on April 21, was assigned to University of South Florida (Tampa, Fla.). "Plasma derived from human umbilical cord blood for th... Read More


US Patent Issued to Minovia Therapeutics, Tel Hashomer Medical Research Infrastructure and Services on April 21 for "Mitochondria-enriched genetically engineered cells and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,410, issued on April 21, was assigned to Minovia Therapeutics Ltd. (Tirat Hacarmel, Israel) and Tel Hashomer Medical Research Infrastructur... Read More


US Patent Issued to Aker BioMarine Human Ingredients AS on April 21 for "Phospholipid compositions for delivery of therapeutic compounds" (Norwegian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,411, issued on April 21, was assigned to Aker BioMarine Human Ingredients AS (Lysaker, Norway). "Phospholipid compositions for delivery of... Read More


US Patent Issued to Institut Gustave Roussy, Institut National de la Sante et de la Recherche Medicale, Universite Paris-Saclay on April 21 for "Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments" (French Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,412, issued on April 21, was assigned to Institut Gustave Roussy (Villejuif, France), Institut National de la Sante et de la Recherche Medi... Read More


US Patent Issued to University of Cincinnati on April 21 for "Engineered probiotics for treatment and immunity against viruses" (Ohio Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,413, issued on April 21, was assigned to University of Cincinnati (Cincinnati). "Engineered probiotics for treatment and immunity against ... Read More


US Patent Issued to THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION on April 21 for "Discovery of novel Akkermansia muciniphila AK32 and application thereof for improving intestinal function" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,414, issued on April 21, was assigned to THE ASAN FOUNDATION (Seoul, South Korea) and UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATI... Read More


US Patent Issued to SERES THERAPEUTICS on April 21 for "Compositions and methods" (Massachusetts, New York, Pennsylvania Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,415, issued on April 21, was assigned to SERES THERAPEUTICS INC. (Cambridge, Mass.). "Compositions and methods" was invented by Gregory Mc... Read More


US Patent Issued to PHI THERAPEUTICS on April 21 for "Compositions and methods for the treatment of skin diseases and conditions including eczema" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,416, issued on April 21, was assigned to PHI THERAPEUTICS INC. (San Francisco). "Compositions and methods for the treatment of skin diseas... Read More


US Patent Issued to CODEX LABS on April 21 for "Compositions and methods for ameliorating symptoms associated with inflammatory skin disorders" (Canadian, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,417, issued on April 21, was assigned to CODEX LABS Corp. (San Jose, Calif.). "Compositions and methods for ameliorating symptoms associat... Read More